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Regulation of protein phosphatase 1 (PP1) is con-
trolled by a diverse array of regulatory proteins.
However, how these proteins direct PP1 specificity
is not well understood. More than one-third of the
nuclear pool of PP1 forms a holoenzyme with the
nuclear inhibitor of PP1, NIPP1, to regulate chro-
matin remodeling, among other essential biological
functions. Here, we show that the PP1-binding
domain of NIPP1 is an intrinsically disordered pro-
tein, which binds PP1 in an unexpected manner.
NIPP1 forms an a helix that engages PP1 at a unique
interaction site, using polar rather than hydrophobic
contacts. Importantly, the structure also reveals
a shared PP1 interaction site outside of the RVxF
motif, theFFmotif. Finally, we show that NIPP1:PP1
substrate selectivity is determined by altered elec-
trostatics and enhanced substrate localization.
Together, our results provide the molecular basis
by which NIPP1 directs PP1 substrate specificity in
the nucleus.
INTRODUCTION
Protein phosphatase 1 (PP1; 38.5 kDa) is a major serine/
threonine phosphatase (Bollen et al., 2010; Peti et al., 2012).
Mammalian genomes contain three different genes that encode
four distinct catalytic subunits of PP1: PP1a, PP1b/d, and the
splice variants PP1g1 and PP1g2, which differ in the amino
acid compositions of the N- and C-terminal extremities. Remark-
ably, free PP1 has very little intrinsic specificity for substrates.
Rather, it is tightly regulated by its interaction with >200 known
targeting proteins (Bollen et al., 2010), proteins that localize
PP1 to distinct regions of the cell and modulate its substrate
specificity. The catalytic site of PP1 is at the intersection of three
potential substrate-binding sites: the hydrophobic, acidic, and
C-terminal grooves. In addition most PP1 regulators and also
some substrates interact with PP1 via a primary PP1-binding1746 Structure 20, 1746–1756, October 10, 2012 ª2012 Elsevier Ltdmotif, the RVxF motif (Hendrickx et al., 2009; Meiselbach et al.,
2006; Wakula et al., 2003). Although this interaction is often
necessary for regulatory protein binding, it does not influence
the enzymatic activity of PP1 because it is 20 A˚ away from the
active site. Additional docking sites, such as the SILK and
MyPhoNE motifs, have been identified, but it is currently unclear
how they influence the substrate specificity of PP1 (Hendrickx
et al., 2009; Hurley et al., 2007; Marsh et al., 2010; Ragusa
et al., 2010; Terrak et al., 2004). Thus, a detailed understanding
and, equally important, the ability to predict how the >200
PP1-targeting proteins direct PP1 specificity from sequence
alone are still missing.
Recently, we have shown that the neuronal PP1-targeting
protein spinophilin directs PP1 specificity via a mechanism of
steric occlusion of alternative substrate-binding sites (Bollen
et al., 2010; Dancheck et al., 2008; Kelker et al., 2009; Marsh
et al., 2010; Ragusa et al., 2010). However, it is likely that PP1
employs a multitude of mechanisms to generate specific
holoenzymes. The nuclear inhibitor of PP1 (NIPP1) is a key
PP1 regulator and functions as a signaling hub in the nucleus.
NIPP1 is one of the evolutionary oldest PP1 regulators, and
most critically, greater than one-third of the nuclear pool of
PP1 forms a holoenzyme with NIPP1 (Jagiello et al., 1995).
NIPP1 (38.5 kDa) contains three functional domains: (1) an
N-terminal Forkhead-Associated (FHA) domain (aa 1–143),
which specifically binds p-Thr residues followed by a Pro; (2)
a central PP1-binding domain (aa 144–225), with 200RVTF203
forming the RVxF motif; and (3) a multifunctional C-terminal
domain (aa 226–351) that binds RNA, has endoribonuclease
activity, and inhibits PP1 using a currently unknown mechanism
(Beullens et al., 2000; Jagiello et al., 1995, 1997; Trinkle-
Mulcahy et al., 1999).
Deletion of the NIPP1 gene in mice causes embryonic lethality
(Van Eynde et al., 2004), which can be explained by the essential
PP1-dependent functions of NIPP1 in transcription, pre-mRNA
splicing, cell-cycle progression, and/or chromatin remodeling
(Bollen and Beullens, 2002; Tanuma et al., 2008; Van Dessel
et al., 2010). A number of substrates have been reported for
the NIPP1:PP1 holoenzyme; however, how NIPP1 turns PP1
into a specific enzyme is currently not understood. Like other
PP1 regulatory proteins (Bollen et al., 2010; Peti et al., 2012;All rights reserved
Figure 1. NIPP1 Is Intrinsically Disordered
(A) Domain architecture of NIPP1.
(B) 2D [1H,15N] HSQC spectrum of NIPP1144–225. The lack of dispersion for the chemical shifts in the
1HN dimension shows that the NIPP1 PP1-binding domain is
an IDP.
(C) Secondary structure propensity data are plotted against NIPP1 residue numbers. These data indicate regions with transient secondary structure (SSP > 0,
a helix; SSP < 0, b sheet).
Structure
Structure of the NIPP1:PP1 HoloenzymeRagusa et al., 2010), NIPP1 has domains that are not involved in
PP1 binding but, instead, serve other functions. For example the
N-terminal FHA domain (Mahajan et al., 2008) likely functions as
a recruitment platform for substrates, including the pre-mRNA-
splicing factor SAP155, which is a component of the U2 small
nuclear ribonuclear protein complex that recruits NIPP1:PP1 to
the spliceosome (Boudrez et al., 2002; Wahl et al., 2009),
and CDC5L, which is involved in pre-mRNA splicing in a
NIPP1:PP1-dependent manner (Boudrez et al., 2000). Some
NIPP1:PP1 substrates, like SAP155 and CDC5L, have overlap-
ping cellular functions, increasing the likelihood that NIPP1 facil-
itates crosstalk between protein complexes that mediate
nuclear-dependent processes. However, because the central
PP1-binding domain of NIPP1 also inhibits the dephosphoryla-
tion of a subset of canonical PP1 substrates, including glycogen
phosphorylase a, NIPP1 was originally identified as a PP1
inhibitor.
Here, we used a combination of NMR spectroscopy, X-ray
crystallography, and biochemistry to elucidate, at a molecular
level, how NIPP1 binds and directs PP1 substrate specificity.
We show that the PP1-binding domain of NIPP1 is highly
dynamic in its unbound state. The high-resolution crystal struc-
ture of the NIPP1:PP1 holoenzyme, together with a significant
number of biochemical experiments, shows that NIPP1 interacts
with PP1 at both conserved and novel interaction sites and also
reveals how the NIPP1:PP1 holoenzyme achieves substrate
specificity. Collectively, this work provides fundamental insights
into themolecular basis of substrate selection by the PP1: NIPP1
holoenzyme.Structure 20, 1746–1RESULTS
The PP1-Binding Domain of NIPP1 Is Intrinsically
Disordered
Numerous NIPP1 single andmultidomain constructs were tested
to determine the optimal PP1-binding domain construct for co-
crystallization (Figure 1A). 2D [1H,15N] HSQC NMR analysis of
NIPP11–225, comprising both the FHA and PP1-binding domains,
showed that, as expected, the FHA domain was well folded.
However,100NHcross-peaks showedvery little chemical-shift
dispersion in the 1HN dimension, indicating that the central PP1-
binding domain of NIPP1 is intrinsically disordered. When
produced alone, the PP1-binding domain (NIPP1144–225) showed
perfect chemical shift overlap with the collapsed chemical-shift
dispersion peaks in NIPP11–225, confirming that NIPP1144–225 is
intrinsically disordered (Figure 1B). In order to gain further
insights, we used carbon chemical shift analysis to test for
preferred secondary structures in NIPP1144–225 (Figure 1C).
Multiple preferred secondary structure elements were detected
in unbound NIPP1144–225 (Marsh et al., 2006): (1) an18% popu-
lated a helix formedby residues 146–154; (2) an17%populated
a helix formed by residues 163–171; (3) an 17% populated
b strand formed by residues 192–197; and (4) an 16% popu-
lated a helix formed by residues 215–221. Interestingly, the
17% populated b strand is just N terminal to the RVxF
(200RVTF203) PP1-docking site of NIPP1, which itself adopts a
b strand 10% of the time. Taken together, these data show
that free NIPP1144–225 has few stretches of preferred secondary
structure elements.756, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1747
Figure 2. The NIPP1-PP1 Interaction
(A) ITC of NIPP11–225 and PP1a7–330, confirming
that NIPP1 is functional.
(B) Cartoon representation of the NIPP1158–216
PP1-binding domain (blue) and PP1a7–307 (gray
surface) complex. The bound Mn2+ ions (magenta
spheres) are located at the active site of PP1.
NIPP1 residues 185–198 were not observed and
are represented as a blue dotted line.
(C) NIPP1 (crystal structure without PP1) with the
three primary interaction sites indicated; V201 and
F203 of the NIPP1 RVxFmotif are shown as sticks.
Residues not visible in the electron density map
are indicated by their one-letter aa code.
See Figure S1.
Structure
Structure of the NIPP1:PP1 HoloenzymeDespite the highly dynamic nature of the NIPP1 PP1-binding
domain in solution, it is functional because it interacts tightly
with both bacterially expressed and native PP1. Isothermal titra-
tion calorimetry (ITC) measurements using NIPP11–225 and re-
combinant PP1a7–330 reported a dissociation constant (KD) of
17.8 nM (Figure 2A). Similarly, ITC measurements with the
NIPP1 PP1-binding domain (NIPP1144–225) and PP1a7–330 re-
ported a KD of 73 nM. Although the latter KD is slightly higher,
these measurements confirm that most of the key direct
interactions between NIPP1 and PP1 are conserved in the
NIPP1144–225:PP1 complex (see Figure S1 available online).
Thus, our ITC data agree well with previous experiments that
mapped the PP1-binding region to the central domain of
NIPP1 (Beullens et al., 1999).
In order to identify which residues within the PP1-
binding domain of NIPP1 interact directly with PP1, we gener-
ated a NIPP1144–225:PP1a7–330 holoenzyme in which only
NIPP1144–225 was
15N labeled. Because free NIPP1144–225 is
an intrinsically disordered protein (IDP) that lacks any significant
long-range interactions, PP1-bound and PP1-unbound resi-
dues of NIPP1144–225 will have significantly different NMR relax-
ation properties. That is, NIPP1 residues that interact directly
with PP1 will be invisible in a 2D [1H,15N] HSQC spectrum,
whereas unbound residues will retain their high-quality NMR
characteristics because they are free to move independently
from their PP1-bound neighbors. Consequently, it is readily
possible to identify the NIPP1144–225 residues that do not bind
PP1 and, in turn, define the optimal NIPP1-binding domain
construct for crystallization efforts. Using this procedure,
we determined the optimal NIPP1 PP1-binding domain con-
struct to include residues 158–216 (referred to hereafter as
NIPP1158–216). ITC measurements using NIPP1158–216 and
PP1a7–330 reported a KD of 104 nM (Figure S1), again con-
firming that most key interactions are conserved in the
NIPP1158–216:PP1 holoenzyme.
The Crystal Structure of the NIPP1:PP1 Holoenzyme
To determine how NIPP1 binds PP1 at a molecular level and to
gain insights into how NIPP1 directs PP1 specificity, we deter-
mined the 2.1 A˚ crystal structure of the NIPP1158–216:PP17–307
complex (hereafter referred to as NIPP1:PP1) by molecular
replacement using PP1 (PDB 3E7A; Kelker et al., 2009) as
a search model. The space group of the crystal was P212121
with four NIPP1:PP1 complexes in the asymmetric unit (Table 1).
All four copies of the NIPP1:PP1 complexes are essentially iden-1748 Structure 20, 1746–1756, October 10, 2012 ª2012 Elsevier Ltdtical (Figure S2). Thus, the remainder of the paper is focused on
NIPP1:PP1 complex AB.
The structure of the NIPP1:PP1 holoenzyme reveals that the
majority, but not all, of the NIPP1 residues become structured
when bound to PP1 (Figure 2B). Specifically, the N-terminal
NIPP1 residues (aa 160–184) bind to the bottom of PP1, whereas
the C-terminal NIPP1 residues (aa 199–214) bind to the top of
PP1. The intervening residues (aa 185–198), which include a
polybasic stretch that functions as a nuclear localization signal
(NLS) and has also been reported to play a role in preventing
the dephosphorylation of a subset of PP1 substrates, were not
visible in the electron density map. The catalytic site of PP1,
which contains two essential Mn2+ ions, is 20 A˚ away from
both the N- and C-terminal NIPP1-structured domains, and
thus, NIPP1 does not interact with the catalytic site of PP1.
A more detailed analysis of the structure of NIPP1:PP1 shows
that NIPP1 interacts with PP1 at three sites (Figure 2C). First, as
expected, NIPP1 occupies the RVxF-binding groove on PP1
(Figure 3). Second, residues C terminal to the RVxF motif form
a b strand (b1) that extends the central b sheet of PP1 by binding
to PP1 b strand b14. A nearly identical RVxF-flanking PP1-
docking site was also identified in spinophilin (Ragusa et al.,
2010) and, thus, identifies a conserved PP1-binding motif that
is shared between PP1 interactors (Figure 4). Third, NIPP1 resi-
dues 160–175 fold into an a helix and interact with PP1 at an in-
teraction site that was not previously identified in any other PP1
holoenzyme structures (Figure 5). Collectively, the NIPP1:PP1
complex buries 3,186 A˚2 of solvent-accessible surface area,
which occludes 12% of the surface of PP1.
RVxF Motif Binding Is Conserved among PP1
Holoenzyme Structures
Three distinct interaction sites are responsible for mediating
NIPP1 and PP1 binding. Interaction site 1, the RVxF interaction,
includes NIPP1 residues 199SRVTFS204, which dock to the RVxF-
binding groove of PP1 (Figures 3A and 3B). Residues Val201 and
Phe203 bind in an extended conformation, in a manner nearly
identical to that seen in the MYPT1:PP1 (Terrak et al., 2004),
inhibitor-2:PP1 (Hurley et al., 2007; Marsh et al., 2010), spinophi-
lin:PP1 (Ragusa et al., 2010), and neurabin:PP1 (Ragusa et al.,
2010) holoenzymes. Specifically, NIPP1 residues Val201 and
Phe203 bind a deep hydrophobic pocket formed by PP1 residues
Ile169, Leu243, Phe257, Arg261, Val264, Leu266, Met283, Leu289,
Cys291, and Phe293 (Figure 3B). This interaction is further stabi-
lized by backbone hydrogen bonds between NIPP1 residuesAll rights reserved
Table 1. Crystallographic Data Collection and Refinement
Statistics
Crystal NIPP1158–216:PP1a7–307
Space group P212121
Unit cell (A˚) a = 76.6, b = 116.0, c = 168.1
No. of copies/AUa 4
Data Processing
Resolution (A˚) 50.0–2.10 (2.14–2.10)a
No. of unique reflections 88,372
Rmerge (%)
b 8.7 (54.9)
I/s 27.3 (4.2)
Completeness (%) 100.0 (100.0)
Redundancy 7.2 (7.3)
Refinement Statistics
Data range (A˚) 47.75–2.10
No. of nonhydrogen atoms 11,550
Solvent 661
Mn2+ 8
RmsdD bond length (A˚)c 0.009
RmsdD bond angle () 1.055
R factor (%)d 15.4
Rfree (%)
e 19.6
Ramachandran Plotf
Core (%) 95.4
Allowed (%) 4.5
Disallowed (%) 0.1 (Leu7, chain C)
Average B factors
Protein atoms 33.7
Solvent 36.1
Mn2+ 23.9
PDB 3V4Y
Highest-resolution shell is shown in parentheses.
aAsymmetric unit.
bRmerge = 1003ShSi jIi(h) <I(h)>j/Sh <I(h)>, where Ii(h) is the ith measure-
ment, and <I(h)> is the weighted mean of all measurements of I(h) for all
Miller indices h.
cRoot-mean-square deviation (rmsdD) from target geometry.
dR factor = 100 3 S jFPFP(calc)j/S FP.
eRfree was calculated from 5% of the data.
fDetermined using MolProbity (Chen et al., 2010).
Structure
Structure of the NIPP1:PP1 Holoenzyme202TFS204 and PP1 residues 289LMC291 and a side-chain/main-
chain hydrogen bond between Asp242 (PP1) and Val201 (NIPP1).
Discovery of a Conserved FF Motif in PP1 Regulators
PP1 interaction site 2 includes NIPP1 residues Ile209 and Ile210,
which dock into a second hydrophobic pocket in PP1 centered
on the top of PP1 b strand b14 (Figure 4A). This hydrophobic
pocket is formed by PP1 residues Leu75, Tyr78, Met282, Ile295,
Leu296, and Lys297 (Figure 4B). Although Ile209 is partially ex-
posed to solvent, Ile210, the NIPP1 residue that becomes most
buried upon PP1 binding (even more than Phe203, the ‘‘F’’ of
the NIPP1 RVxF motif), is completely occluded from solvent.
NIPP1 binding at this site is also stabilized by multiple back-Structure 20, 1746–1bone-backbone, backbone-side chain, and side chain-side
chain hydrogen bonds. Namely, the position of Tyr78 in the
NIPP1:PP1 complex is stabilized by a hydrogen bond between
the Tyr78 hydroxyl group and the carboxylate of NIPP1 residue
Glu208. A similar hydrogen bond is present on the opposite
side of the bound NIPP1 chain, mediated by the hydroxyl of
PP1 Tyr255 and the carboxylate of NIPP1 Asp207 (Figure 4B).
NIPP1 residues 208–210 also form a short b strand (NIPP1 b1)
that hydrogen bonds with PP1 residues 293–297 (PP1 b14), ex-
tending the central PP1 b sheet by one strand (Figure 4C).
Collectively, the hydrophobic interactions between NIPP1 resi-
dues Ile209 and Ile210 and PP1 as well as the hydrogen bonds
between both PP1 (Tyr) and NIPP1 (Asp/Glu) side chains and
parallel b strands (PP1b14–NIPP1b1) stabilize the interactions at
this site.
Unexpectedly, spinophilin makes similar, but not identical,
interactions with PP1 (Figure 4D). Namely, spinophilin residues
Val458 and Phe459 make hydrophobic interactions with PP1 that
are similar to those made by Ile209 and Ile210 in the NIPP1:PP1
holoenzyme (Figure 4E). Specifically, Val458, like Ile209 from
NIPP1, is partially exposed, whereas Phe459 interacts in the
same PP1 pocket as NIPP1 residue Ile210. However, this PP1
hydrophobic pocket is slightly different between the two holoen-
zymes due to a change in the conformation of PP1 residue Tyr78
between the NIPP1:PP1 and spinophililn:PP1 complexes. In the
spinophilin:PP1 holoenzyme the PP1 Tyr78 side chain points
away from spinophilin Phe459, which allows the two rings to
base stack on one another. In contrast, in the NIPP1:PP1 holoen-
zyme, the side chain of Tyr78 rotates by nearly 180
, so that it
forms the ‘‘lid’’ of the Ile210-binding pocket. If Tyr78 adopted
this conformation when bound to spinophilin, it would clash
with spinophilin residue Phe459, rationalizing why the side chain
adopts a distinct conformation in the spinophilin:PP1 complex
(Figures 4B and 4E). Further comparison with all other available
PP1 structures reveals that, in contrast to most PP1 residues,
which are largely conformationally invariant, the side-chain posi-
tion of PP1 residue Tyr78 is highly variable, adopting a range of
conformations depending on the PP1 interaction partner (Fig-
ure S3). Thus, the conformational variability of PP1 residue
Tyr78 enables PP1 to create distinct pockets to accommodate
different PP1-interacting proteins at this PP1 hydrophobic
pocket. Because the PP1 regulatory proteins that engage this
site do so via two sequential hydrophobic residues, i.e., via
a FF motif, we have named this the PP1 FF-binding pocket.
The NIPP1helix-PP1 Interface Defines a Unique
Interaction Site on PP1
Interaction 3, the NIPP1helix interaction, includes NIPP1 residues
160–184, with residues 160–175 forming a four turn a helix
(Figures 2C, 5A, and 5B) that docks onto the bottom surface of
PP1. Interestingly, in their unbound state, NMR chemical shift
analysis showed that these NIPP1 residues also exhibited an
20% a-helical preference. Thus, this interaction between
NIPP1 and PP1 is likely mediated by conformational selection,
where a preformed conformation is used to guide an efficient
binding event (Marsh et al., 2010). Remarkably, unlike interaction
sites 1 and 2, which are dominated by hydrophobic interactions,
the NIPP1helix is anchored to PP1mainly by electrostatic interac-
tions, with very few hydrophobic contacts. The interaction is756, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1749
Figure 3. NIPP1 Interaction with the PP1 RVxF-Binding Pocket
(A) The interaction of NIPP1 Val201 and Phe203 in the PP1 RVxF-binding
pocket. NIPP1 is illustrated as a cartoon and sticks (blue; with nitrogen atoms
in dark blue and oxygen atoms in red) and PP1 as a surface (gray; the RVxF-
binding pocket is highlighted in light blue).
(B) Close-up view of RVxF interaction. Colored as in (A), except PP1 residues
that make up the RVxF-binding pocket are illustrated as sticks and labeled.
Hydrogen bonds between PP1 and the NIPP1 RVxF motif are represented as
black dashes. The side chain of Arg200 has been omitted for clarity.
Structure
Structure of the NIPP1:PP1 Holoenzymecentered on NIPP1 residue Asn174 and PP1 residue Met190
(Figures 5C and 5D). The NIPP1 helix residues that are most
buried upon PP1 binding, in descending order, are Asn174,
Ile177, Lys175, Thr171, Thr167, and Asn170, whereas the most
buried PP1 residues are Pro192, Met190, and Pro196. Met190, in
particular, adopts a rotamer conformation in the NIPP1:PP1
holoenzyme that differs from all other PP1 structures in order
to accommodate the imidazole ring of His173. This allows the
side chain of Asn174 to make hydrogen bonds with the backbone
amide and carbonyl of Met190. Because NIPP1 is the first PP1
regulatory protein that, to our knowledge, has been shown to
bind PP1 at this surface, this PP1 interaction demarcates a novel
PP1 interaction site.
Although the interface between the NIPP1helix and PP1 is
largely polar, the surface of the NIPP1helix that faces the
solvent is unusually hydrophobic. In particular, Leu166 and
Phe169, which are closest to the anchoring residue Asn174,
face outward away from PP1. Leu180 and Ile182 are also
solvent accessible. This causes the positively charged surface
of PP1 at the NIPP1helix-binding site to become more hydro-
phobic in nature. In addition the NIPP1helix termini are confor-
mationally variable. The asymmetric unit of the NIPP1:PP1
crystal contains four copies of the NIPP1:PP1 holoenzyme
(Figures 5E and S2), which differ from one another primarily
in the conformation and number of residues in the NIPP1helix.
The residues visible in the NIPP1:PP1 electron density map
ranged from 156–183 (holoenzyme copy 4; Figure 5E, far right)
to 156–178 (holoenzyme copy 2; Figure 5E, second from right);
the NIPP1helix residues visible in all four complexes are 160–
178. An overlay of all four copies of the holoenzyme (superim-
posed using PP1) reveals that the termini of the NIPP1helix are
variable, adopting a range of distinct conformations that
reflect different local environments in the crystal. In contrast
the interactions made and the conformations adopted by resi-
dues at the center of the NIPP1helix (residues 162–175) are
structurally conserved (Figure 5F). This shows that NIPP1helix
residues 162–175 comprise the core of the NIPP1helix-PP1
interaction.1750 Structure 20, 1746–1756, October 10, 2012 ª2012 Elsevier LtdThe Effect of NIPP1158–216 on the Activity of PP1 Is
Substrate Dependent
NIPP1 was originally identified as a potent inhibitor of PP1
(Beullens et al., 1992). However, later data revealed that inhibi-
tion of PP1 phosphatase activity by the central domain of
NIPP1 is substrate dependent (Beullens et al., 2000). Indeed,
whereas NIPP1143–224 potently inhibited PP1 when glycogen
phosphorylase a was used a substrate (a specific substrate of
the Gm:PP1 holoenzyme), the dephosphorylation of myelin
basic protein by PP1 was only weakly affected. Critically, our
crystal structure of the NIPP1158–216:PP1a7–307 holoenzyme re-
vealed that NIPP1 does not bind near the catalytic site of PP1
and thus does not inhibit PP1 activity by blocking access to
this site. Consistent with these results, NIPP1158–216 was iden-
tified as a noncompetitive inhibitor for the dephosphor-
ylation of glycogen phosphorylase a (Figure 6A). In-line with
our previous work, we showed that the activity of the
NIPP1158–216:PP1a7–330 holoenzyme against glycogen phos-
phorylase a was 4- to 5-fold higher following trypsinolysis
(Figure 6B), which digests NIPP1 and releases active PP1
(Beullens et al., 2000). This confirms that NIPP1158–216 inhibits
the phosphorylase phosphatase activity of PP1. In contrast
the dephosphorylation of SAP155 and CDC5L was not affected
by trypsinolysis of NIPP1158–216:PP1. That is, their dephosphor-
ylation was nearly equally efficiently performed by intact
NIPP1:PP1 and free PP1.
Interestingly, the measured Michaelis-Menten constant, KM,
values of the NIPP1:PP1 holoenzyme for these substrates were
similar, i.e., 4.2 ± 0.3 mM for glycogen phosphorylase a, 2.9 ±
0.4 mM for SAP155, and 3.0 ± 0.4 mM for CDC5L (for comparison,
diffusion-controlled dephosphorylation of pNPP, p-Nitrophenyl
Phosphate, has a KM of 4.8 ± 0.1 mM). Thus, whereas the KM
values were nearly identical for these substrates, their kcat values
were differentially affected by NIPP1. Finally, the dephosphory-
lation of glycogen phosphorylase a by PP1 purified from rabbit
skeletal muscle (mixture of all PP1 isoforms; Figure 6C) or bacte-
rially expressed PP1a7–330 (Figure S4) was inhibited by
NIPP1158–216 but did not affect the dephosphorylation of
SAP155 and CDC5L, even when added in a molar excess.
This shows that the substrate specificity and activity of the
NIPP1:PP1 holoenzyme are independent of the source of PP1.
Inhibition of the Phosphorylase Phosphatase Activity
by NIPP1158–216
Previously, the inhibitory activity of NIPP1 was correlated with
amino acids N terminal to the NIPP1 RVxF motif and C terminal
to the NIPP1 helix (191RPKRKRKNSR200) (Beullens et al., 1999).
These residues were also shown to function as a nuclear locali-
zation sequence. Interestingly, no electron density was observed
for the majority of these residues in the NIPP1:PP1 holoenzyme
crystal structure, indicating that these NIPP1 residues stay
flexible even when bound to PP1. Based on these results, the
inability of the NIPP1:PP1 holoenzyme to dephosphorylate
glycogen phosphorylase a seems to involve highly dynamic elec-
trostatic interactions.
To gain further insight into this mechanism, we analyzed the
MYPT1:PP1 holoenzyme structure (Terrak et al., 2004). MYPT1
was also originally defined as a PP1 inhibitor because it too
inhibited the dephosphorylation of glycogen phosphorylase a.All rights reserved
Figure 4. Tyr78 Defines a Malleable Binding
Pocket for PP1-Interacting Proteins
(A) The interaction of NIPP1 Ile210 in the PP1 FF-
binding pocket. NIPP1 is illustrated as a cartoon
with sticks (blue; nitrogen atoms in dark blue and
oxygen atoms in red) and PP1 as a surface (gray;
the FF-binding pocket is highlighted in beige and
the RVxF-binding pocket in light blue).
(B) Close-up view of Ile210 interaction. Colored as
in (A), except residues that make up the FF-
binding pocket are shown as sticks and labeled.
Hydrogen bonds between PP1 and the NIPP1 FF
motif are represented as black dashes. The side
chain of Glu213 has been omitted for clarity. **, the
location of Leu296.
(C) NIPP1 forms a short b strand, b1, that interacts
with PP1 b14 to extend one of the two central
b sheets in PP1 (colored in beige).
(D) Both NIPP1 (top, blue) and spinophilin (coral,
bottom) interact with PP1 via b14; for reference the
‘‘F’’ residues of their respective RVxF motifs are
shown as sticks and labeled.
(E) Overlay of the NIPP1:PP1 (blue:light gray) and
spinophilin:PP1 (coral:dark gray) holoenzymes
illustrating the change in conformation of Tyr78
to accommodate NIPP1 Ile210. Hydrogen bonds
between PP1 and NIPP1 are represented as black
dashes.
See Figure S3.
Structure
Structure of the NIPP1:PP1 HoloenzymeHowever, as observed in the NIPP1:PP1 holoenzyme, the
active site of PP1 is also fully accessible in the MYPT1:PP1
holoenzyme. Interestingly, like NIPP1, MYPT1 also has a poly-
basic stretch (30KRKK33) N terminal to its RVxF motif
(35KVKF38). Although electron density was visible for these
residues in this complex, these residues have the highest B
factors indicating that they also interact more weakly with
PP1. In the MYPT1:PP1 holoenzyme, most interactions in this
region are mediated via the backbone, likely enabling the
side chains to interact with substrates and/or PP1 itself. To
confirm that these polybasic amino acids in NIPP11–224 are
important for the inhibition of glycogen phosphorylase a, we
created a NIPP1 mutant (191RPKRKRKNSR200 was mutated
to 191RPAAAAANSR200). As expected, glycogen phosphorylase
a activity assays showed that poly-A-mutated NIPP11–224 has
a reduced inhibitory potency (Figure 7), which correlates well
with previous findings (Beullens et al., 2000). Together, these
data show that the stretch of dynamic, polybasic amino
acids N terminally preceding the RVxF motif residues in
NIPP1 and MYPT1 are necessary for the inhibition of the phos-
phorylase phosphatase activity by these two PP1-interacting
proteins.
NIPP1 Enhances the Dephosphorylation of Specific
Substrates by Associated PP1
To understand how the FHA domain of NIPP1 affects the activity
of associated PP1 toward its substrates, we compared the
dephosphorylation of CDC5L and SAP155 by free PP1 and the
NIPP11–225:PP1 holoenzyme. For these experiments, SAP155
or CDC5L was first phosphorylated with recombinant CycA2/
CDK2, which resulted in six (CDC5L) or nine (SAP155) phosphor-
ylated residues, as verified by MS. We have previously shown
that phosphorylation by CycA2/CDK2 enables the binding ofStructure 20, 1746–1SAP155 and CDC5L to the FHA domain of NIPP1 (Boudrez
et al., 2000, 2002).
As shown in Figure 8A, NIPP11–225:PP1 dephosphorylated
SAP155 and CDC5L severalfold more efficiently than free PP1.
In contrast the dephosphorylation of pNPP, which does not
bind to the FHA domain, was not affected by the presence of
NIPP11–225. These data suggested that the recruitment of
SAP155 and CDC5L by the FHA domain promoted their dephos-
phorylation by PP1. Consistent with this notion, the PP1 active
site is not altered by NIPP1 binding, as demonstrated by the
NIPP1:PP1 crystal structure and by the uniform dephosphoryla-
tion efficiency of PP1 and NIPP11–225:PP1 for pNPP (Figure 8A).
Therefore, changes outside the PP1 active site must be respon-
sible for the increased dephosphorylation efficiency of SAP155
and CDC5L by the NIPP1:PP1 holoenzyme. Specifically, it
must result from a modification of the PP1 substrate-binding
surface, by a change in the surface electrostatics, by steric
blocking, by enlargement of substrate-binding sites, by an
increase in local concentration of substrates, or any combination
thereof. Strikingly, the binding of NIPP1 to PP1 has a significant
impact on the overall surface charge of PP1. Indeed, the top
(RVxF site) of the NIPP1:PP1 holoenzyme becomes nearly
entirely negatively charged in the presence of NIPP1, whereas
the bottom (NIPP1helix site) loses a significant positively charged
patch and becomes more hydrophobic and acidic (Figure 8B).
Thus, it is very likely that this considerable change of surface
electrostatics, as already proposed for MYPT1:PP1, together
with the recruitment of the substrates by the NIPP1 FHA domain
(proximity effect), determines the substrate specificity of
NIPP1:PP1. In conclusion, whereas NIPP1 is a potent inhibitor
against a subset of substrates including the most commonly
used substrate, glycogen phosphorylase a, NIPP1 is not an
inhibitor of the tested physiological substrates.756, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1751
Figure 5. The NIPP1 Helix Interaction Site
(A) PP1 (gray; with the NIPP1 helix interaction site shown in yellow) and NIPP1 (blue) are shown as surfaces.
(B) Same as (A), except NIPP1 has been rotated by 180 relative to PP1 so that residues constituting the NIPP1helix:PP1 interface are visible. Interacting residues
are shown as sticks with the corresponding surface of PP1 (left panel) and the NIPP1helix (right panel) colored in yellow. Met190 of PP1 and Asn174 of NIPP1 are
underlined, as the Asn174 side chain, which is completely buried, forms hydrogen bonds with the amide nitrogen and carbonyl oxygen of Met190.
(C) Stereo view of the NIPP1helix:PP1 interaction with NIPP1 and PP1 residues shown as sticks (oxygen atoms, red; nitrogen atoms, dark blue). Hydrogen bonds
are indicated by black dashed lines.
(D) Same as (C), except only those residues that participate in hydrogen-bonding interactions are shown.
(E) The NIPP1 helices from the four NIPP1:PP1 holoenzymes present in the asymmetric unit. The residues visible in the electron density map are indicated;
NIPP1helix residues Glu160-Ser178 are present in all four holoenzymes.
(F) Overlay of the four NIPP1:PP1 holoenzymes (superimposed using PP1). Left, the NIPP1 helices are shown as sticks on the surface of PP1. Right, Stereo view of
the superimposed NIPP1 helices.
See Figure S2.
Structure
Structure of the NIPP1:PP1 HoloenzymeDISCUSSION
Our biochemical and NMR data of the NIPP1 PP1-binding
domain demonstrate that NIPP1 is an IDP. NIPP1 undergoes
a folding-upon-binding transition upon complex formation with
PP1 to form the functional NIPP1:PP1 holoenzyme. As antici-
pated, NIPP1 binds in the RVxF-binding groove of PP1.
However, additional interaction sites, including a hydrophobic
interaction with the FF motif-binding grove formed by PP1
Tyr78 and b strand 14, are necessary for its nanomolar interaction
with PP1. Notably, this Tyr78 is conserved in PP1 in nearly all
isoforms and species, including all human isoforms and in organ-
isms as diverse as Schistosoma mansoni and Trichoplax adhae-
rens (to our knowledge, the only organism identified without
a tyrosine at this position is Lepeophtheirus salmonis, where it1752 Structure 20, 1746–1756, October 10, 2012 ª2012 Elsevier Ltdis replaced by a cysteine). In contrast, in PP2A and PP3 (PP3,
calcineurin), the structurally equivalent residue is replaced by
an isoleucine or valine, respectively. Thus, the specificity of
PP1 for these regulators is likely mediated in part by the pres-
ence of a tyrosine residue at this binding pocket in PP1.
Interestingly, NIPP1 residues 160–175, which only show an
20% populated a helix in unbound NIPP1, become fully
populated when bound to PP1. In contrast with the RVxF and
the FF hydrophobic pocket interactions, which are mainly
stabilized by hydrophobic contacts, the NIPP1helix interaction
is stabilized predominately by electrostatic interactions.
Importantly, the FF hydrophobic pocket interaction was also
observed in the spinophilin:PP1 complex and is thus, to our
knowledge, the first structurally confirmed interaction site,
outside of the RVxF-binding groove, that has been detected inAll rights reserved
Figure 6. Effects of NIPP1158–216 on the Activity of PP1
(A) Lineweaver-Burk plot of the dephosphorylation of glycogen phosphorylase
a by 1 nM native PP1 in the absence or presence of 0.5 nM NIPP1158–216. The
results represent the mean ± SEM (n = 4).
(B) Phosphatase activity of the recombinant holoenzyme NIPP1158–216:
PP1a7–330 against glycogen phosphorylase a (Phos a), SAP155, or CDC5L
before or after a trypsin treatment. The holoenzyme activity toward glycogen
phosphorylase a with trypsin treatment was used as control (100%). The
activities are expressed as mean ± SEM (n = 3).
(C) Dephosphorylation of glycogen phosphorylase a, SAP155, or CDC5L by
8 nM native PP1 in the presence of increasing concentrations of NIPP1158–216.
The activities are expressed as mean ± SEM (n = 3).
See Figure S4.
Figure 7. Mutation of the Polybasic Stretch Alleviates the Inhibitory
Potency of NIPP11–224
Dephosphorylation of glycogen phosphorylase a by recombinant PP1a in
the presence of increasing concentrations of NIPP11–224-wild-type (WT) or
poly-A-mutated NIPP11–224 (MT). The activities are expressed as mean ± SEM
(n = 4).
Structure
Structure of the NIPP1:PP1 Holoenzymemultiple PP1 holoenzymes (Peti et al., 2012; Ragusa et al.,
2010). Therefore, there is now optimism that the analysis of
additional PP1 holoenzymes will lead to a common under-Structure 20, 1746–1standing of how PP1 regulatory proteins bind and direct the
activity of PP1.
Direct comparison with the structure of the spinophilin:PP1
holoenzyme shows that whereas both spinophilin and NIPP1
are IDPs, spinophilin folds completely upon binding to PP1 and
becomes rigid, whereas NIPP1 retains some flexibility because
electron density for NIPP1 residues 185–198 was not observed.
This shows that different IDP PP1 regulators adopt different
levels of structure and rigidity when bound to PP1.We previously
showed that spinophilin inhibits the dephosphorylation of the
canonical PP1 substrate glycogen phosphorylase a by binding
to the C-terminal substrate-binding groove and blocking its
access to PP1 residue Asp71, a residue previously shown to be
critical for glycogen phosphorylase a binding. Here, we show
that a stretch of dynamic polybasic amino acids, N terminal to
the RVxF motif of NIPP1, is necessary for the inhibition of the
dephosphorylation of a subset of PP1 substrates, including
glycogen phosphorylase a. These results suggest that the
increased, localized positive charge on NIPP1 influences
glycogen phosphorylase a substrate binding and/or positioning
and thus likely inhibits its PP1-mediated dephosphorylation via
a mechanism similar to that proposed for substrate selection
by the MYPT1:PP1 holoenzyme, i.e., altered electrostatics
(Terrak et al., 2004).
Thus far, two distinct modes of substrate selection by PP1
holoenzymes have been reported. Spinophilin:PP1 selects
substrates by sterically occluding specific substrate-binding
sites (Ragusa et al., 2010). This mechanism for altering the
substrate specificity of PP1 is different to that reported for the
MYPT1:PP1 holoenzyme, whichwas proposed to be determined
by altered electrostatics, as well as by potentially extending
substrate-binding grooves (Terrak et al., 2004). The NIPP1:PP1
holoenzyme appears to function in a manner more similar to
that of MYPT1:PP1. Specifically, the presence of NIPP1 signifi-
cantly changes the electrostatic charge distribution of the
surface of the NIPP1:PP1 holoenzyme when directly compared756, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1753
Figure 8. The FHA Domain Promotes the
Dephosphorylation of SAP155 and CDC5L
(A) Relative dephosphorylation of pNPP (green),
CDC5L (blue), and SAP155 (purple) using either
recombinant PP1 or the recombinant NIPP11–225:
PP1a7–330 holoenzyme. The relative dephosphor-
ylation reactions are expressed as weighted
means ± weighted SEM (nR 2).
(B) Electrostatic surface of PP1 (left panels)
and the NIPP1:PP1 holoenzyme (right panels);
positively charged surfaces are in blue, nega-
tively charged surfaces in red, and neutral
surfaces in white. Three orientations are shown:
the standard orientation with the active site in
the center of the molecule (the bound Mn2+ ions
are in magenta; top); a view that highlights the
RVxF-binding pocket (middle); and a view
that highlights the NIPP1helix-binding surface
(bottom).
Structure
Structure of the NIPP1:PP1 Holoenzymewith PP1. We have also shown that the NIPP1 FHA domain plays
a role in substrate recruitment. Recent peptide:NIPP1 FHA
domain NMR interaction studies showed that this interaction is
weak but strong enough to achieve further selectivity for specific
phosphorylated substrates (Kumeta et al., 2008).
These observations begin to explain the striking diversity of
PP1 holoenzymes, each of which may form a truly unique
enzyme with distinctive properties. This is made even more
intriguing by the fact that the number of identified PP1-targeting
proteins (200) is still increasing (Bollen et al., 2010; Hendrickx
et al., 2009; Peti et al., 2012). If the diversity of interactions
observed for PP1 is conserved across ser/thr phosphatases,
it would allow the 40 ser/thr protein phosphatases to form
hundreds of unique holoenzymes, ensuring that they are as
specific as the 428 known ser/thr protein kinases.
EXPERIMENTAL PROCEDURES
Experimental procedures for cloning and expression, ITC, and PP1 inhibition
assays are either previously described (Kelker et al., 2009; Peti and Page,
2007) or included as Supplemental Experimental Procedures.
Protein Purification
Bacteria were lysed by high-pressure homogenization (Avestin C3 EmulsiFlex)
in the presence of EDTA-free protease inhibitor cocktail (Roche). For the
expression of NIPP1, CDC5L, SAP155, CDK2, and Cyclin A2, the lysates
were clarified by centrifugation at 50,000 3 g. For PP1, lysate was clarified
by ultracentrifugation at 100,000 3 g. For the purification of NIPP11–225,
NIPP1144–225, and NIPP1158–216, clarified lysate was loaded onto a HisTrap
HP column (GE Healthcare) and eluted with a 5–500 mM imidazole gradient.
Peak fractions were pooled and dialyzed overnight at 4C (20 mM Tris
[pH 7.5], 50 mM NaCl for NIPP1144–225 and NIPP1158–216, or 200 mM NaCl
for NIPP11–225) with TEV protease to simultaneously facilitate MBP-tag
cleavage. The following day the cleaved protein was incubated with Ni2+-
NTA beads (QIAGEN) at 4C, and the flowthrough was collected. The IDPs
NIPP1144–225 and NIPP1158–216 were subsequently heat purified at 90
C
(600 rpm, 15min). The supernatant was collected, concentrated to 1mM, flash
frozen in liquid nitrogen, and stored at 80C until further use. Following the
Ni2+-NTA subtraction step, NIPP11–225 was further purified by size exclusion
chromatography (SEC; Superdex 75 26/60 [GE Healthcare]), concentrated
to 1 mM, flash frozen, and stored at 80C. For NMR experiments, 1 mM
13C/15N-labeled NIPP1144–225 was used (20 mM Na-phosphate [pH 6.5],
50 mM NaCl, 0.5 mM TCEP, 10% D2O).1754 Structure 20, 1746–1756, October 10, 2012 ª2012 Elsevier LtdSAP155 and CDC5L were purified by HisTrap HP affinity chromatography,
dialyzed overnight, and purified by gel filtration on Superdex 200 column in
20 mM Tris-HCl (pH 8.0), 250 mM NaCl. The proteins were in vitro phosphor-
ylated by incubation with purified CycA2/CDK2 in 50 mM Tris (pH 7.5), 2 mM
DTT, 2 mMMgCl2, 100 mMATP, 0.03 mg/ml BSA at 30
C for 90 min. The reac-
tion was stopped by the addition of 10 mM EDTA, and phosphorylation was
confirmed using Pro-Q Diamond phosphoprotein gel stain (Life Technologies)
and MALDI-TOF MS analysis. In addition to the Pro-Q Diamond phosphopro-
tein gel stain analysis, for some experiments, [g-32P]ATP was used in the
dephosphorylation reactions. In these experiments, phosphorylation reactions
were stopped by the addition of 20 mM Roscovitine and analyzed by autoradi-
ography. Phosphorylated substrates were flash frozen and stored at 80C.
Glycogen phosphorylase a was prepared as described previously (Beullens
et al., 1999).
The CycA2/CDK2 kinase was copurified by mixing bacterial pellets ex-
pressing CycA2 and CDK2 prior to lysis. Clarified lysate containing the kinase
complex was immobilized on Ni2+-NTA resin and eluted with 200 mM
imidazole prior to overnight dialysis at 4C in SEC buffer (20 mM Tris
[pH 7.5], 500 mM NaCl, 1 mM DTT). Next, the complex was purified using
SEC (Superdex 200 26/60). Peak fractions were again dialyzed overnight at
4C (20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM MgCl2, 0.005% Tween 20,
10% glycerol), flash frozen, and stored at 80C.
To purify the NIPP1158–216:PP1 holoenzyme complex for crystallization
trials, a cell pellet expressing PP1a7–307 was lysed in PP1 Lysis Buffer
(25 mM Tris [pH 8.0], 700 mM NaCl, 5 mM imidazole, 1 mM MnCl2, 0.1%
Triton X-100), clarified by ultracentrifugation, and immobilized on Ni2+-NTA
resin. Bound His6-PP1 was washed with PP1 Buffer A (25 mM Tris [pH 8.0],
700 mM NaCl, 5 mM imidazole, 1 mM MnCl2), followed with a stringent
wash containing 5% PP1 Buffer B (25 mM Tris [pH 8.0], 700 mM NaCl,
0.25 M imidazole, 1 mM MnCl2) and low-salt PP1 Buffer A wash (25 mM
Tris [pH 8.0], 50 mM NaCl, 5 mM imidazole, 1 mM MnCl2) prior to incubation
with NIPP1158–216 for 1 hr at 4
C. The complex was eluted in low-salt PP1
Buffer B (25 mM Tris [pH 8.0], 50 mM NaCl, 0.25 M imidazole, 1 mM
MnCl2). Next, the complex was purified by SEC (Superdex 200 26/60;
20 mM Tris [pH 7.5], 500 mM NaCl, 5 mM DTT). Peak fractions were incu-
bated overnight with TEV protease at 4C. The following day, the NaCl
concentration of the sample was reduced to 50 mM prior to purification by
ion-exchange chromatography (Mono-Q 5/50 GL [GE Healthcare]) and eluted
using a 0.05–1 M NaCl gradient. NIPP1158–216:PP1-containing fractions were
pooled and SEC purified (Superdex 75 26/60; 20 mM Tris [pH 7.5], 500 mM
NaCl, 0.5 mM TCEP). Fractions containing the NIPP1158–216:PP1 complex
were concentrated to 5.5 mg/ml and immediately used for crystallization
trials.
For dephosphorylation assays, purification of PP1a7–330 and NIPP1:PP1
holoenzymes proceeded as described above, using only a single-step Ni2+-
NTA affinity purification at 4C. PP1 was eluted following the stringent wash,All rights reserved
Structure
Structure of the NIPP1:PP1 Holoenzymewhereas NIPP1:PP1 holoenzymes were eluted following complex formation
and a low-salt PP1 Buffer A wash. The purified proteins were imme-
diately diluted to 0.08 and 1 mM for use in protein substrate and pNPP
(p-Nitrophenyl Phosphate) dephosphorylation assays, respectively. Native
PP1was purified from rabbit skeletal muscle as described previously (Beullens
et al., 1999).
NMR Measurements
NMR measurements were performed at 298 K on a Bruker Avance 500 MHz
spectrometer equipped with a TCI HCN z-gradient cryoprobe. Chemical shift
referencing, NMR spectra processing, chemical shift assignments, and
secondary structure propensity calculations were performed as described
by Dancheck et al. (2008).
Crystallization, Data Collection, and Structure Determination
Crystals (5.5 mg/ml NIPP1158–216:PP1; 20 mM Tris [pH 7.5], 500 mM NaCl,
0.5 mM TCEP) were obtained from successive rounds of fine screening
using the sitting drop (200 nl) vapor diffusion method at 4C. Large, rod-
shaped crystals formed in 80 mM Bis-Tris (pH 6.9), 320 mM KF, 21%
(w/v) PEG1500. Crystals were cryoprotected by a 20 s soak in mother liquor
supplemented with 30% glycerol and immediately flash frozen. A data set
from a single NIPP1158–216:PP17–307 crystal was collected at Beamline X25
at the National Synchrotron Light Source at Brookhaven National Labora-
tory. The structure was determined using molecular replacement (Phaser
in PHENIX; Adams et al., 2010) using PP1 (PDB 3EA7; Kelker et al.,
2009) as the search model in space group P212121 to 2.1 A˚ resolution. Clear
electron density was observed for the portions of the NIPP1158–216 bound to
each PP1 in the ASU (four PP1:NIPP1 complexes). The initial models of the
four NIPP1158–216 chains were built using Autobuild (PHENIX; Adams et al.,
2010). The structure was completed by successive rounds of manual
building using Coot (Emsley et al., 2010) and refinement using PHENIX
(Adams et al., 2010). MolProbity was used to evaluate model quality
(Chen et al., 2010). Stereochemical analysis showed that 99.9% of the resi-
dues were in the allowed region of the Ramachandran diagram, with one
outlier (Leu7, chain C). Analyses of protein:protein interactions and buried
surface area were carried out using the Protein Interactions Calculator
and NACCESS (Tina et al., 2007). Structure figures were created using
PyMOL (The PyMOL Molecular Graphics System, Version 1.2r3pre;
Schro¨dinger). Data collection and structure refinement statistics are re-
ported in Table 1.
Dephosphorylation Reactions
Dephosphorylation reactions were initiated by the addition of 0.02 mM (holo)
enzyme to a reaction mixture containing 1 mM phosphorylated CDC5L260–606
or SAP1551–491 to a final enzyme:substrate ratio of 1:50. Reactions were
incubated at 30C for 30 min and quenched by the addition of SDS-PAGE
loading buffer and boiling for 10 min at 100C. Samples were resolved by
SDS-PAGE. The phospho-protein and total protein content of substrate
bands were detected using Pro-Q Diamond phosphoprotein gel stain and Sy-
pro Ruby protein gel stain, respectively (Life Technologies). The resulting
fluorescence signal was measured using a Typhoon 9410 Variable Mode
Imager (GE Healthcare) with excitation and emission wavelengths of 532
and 560 nm, respectively. Bands were quantified using ImageQuant TL (GE
Healthcare). Pro-Q results were corrected for total protein as previously
described by Jacques et al. (2008) and Ragusa et al. (2010). The dephos-
phorylation experiments shown in Figures 6 and 7 were performed with radio-
actively phosphorylated substrates, using the same conditions as described
above. The dephosphorylation was quantified by Serenkov counting after
SDS-PAGE. The dephosphorylation of glycogen phosphorylase a was
measured by quantification of the released Pi, as described previously
(Beullens et al., 1999).
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